Provided by Tiger Trade Technology Pte. Ltd.

Amgen

442.24
-1.6000-0.36%
Post-market: 443.000.7600+0.17%19:59 EDT
Volume:2.10M
Turnover:932.33M
Market Cap:238.14B
PE:27.47
High:447.03
Open:443.26
Low:441.26
Close:443.84
52wk High:447.03
52wk Low:269.77
Shares:538.48M
Float Shares:536.99M
Volume Ratio:0.83
T/O Rate:0.39%
Dividend:9.80
Dividend Rate:2.22%
EPS(TTM):16.10
EPS(LYR):14.23
ROE:91.47%
ROA:8.67%
PB:20.37
PE(LYR):31.08

Loading ...

Amgen is Maintained at Equal-Weight by Barclays

Dow Jones
·
Jul 29

Amgen price target raised to $360 from $350 at Barclays

TIPRANKS
·
Jul 29

Sino Biopharmaceutical Stock Rises 2.8% in Hong Kong

Dow Jones
·
Jul 29

U.S. Research ROUNDUP-Boeing, Coca-Cola, PayPal

Reuters
·
Jul 29

Earning Preview: Amgen this quarter’s revenue is expected to increase by 5.44%, and institutional views are broadly bullish

Earnings Agent
·
Jul 29

Amgen Inc Stock (AMGN) Moved Up by 4.02% on Jul 28: What Signal Does It Send?

TradingKey
·
Jul 29

Movement Alert|Amgen Rises 3.64% in Regular Trading, Multiple Brokerages Raise Target Prices Ahead of Earnings

Market Focus
·
Jul 28

Barclays Adjusts Amgen Price Target to $360 From $350, Maintains Equalweight Rating

MT Newswires Live
·
Jul 28

Amgen Halts Key Phase 3 Rocatinlimab Study, Resetting Expectations in Dermatology

TIPRANKS
·
Jul 28

Amgen Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jul 25

Amgen Says Strongly Disagrees with FDA'S Proposal to Withdraw Tavneos from the U.S. Market

Reuters
·
Jul 24

Amgen : Submits Data to FDA Seeking Hearing on Tavneos Avacopan in Response to Withdrawal Proposal

THOMSON REUTERS
·
Jul 24

Amgen Inc: Strongly Disagrees with Fda's Proposal to Withdraw Tavneos from the U.S. Market

THOMSON REUTERS
·
Jul 24

Ema's Chmp: Recommends Granting Marketing Authorisation for Icotyde

THOMSON REUTERS
·
Jul 24

What Amgen (AMGN)'s Blocked Colorado Enbrel Price Cap Means For Shareholders

Simply Wall St.
·
Jul 24

Imagenebio Names Yanina Grant-huerta CFO

Reuters
·
Jul 24

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 24

Amgen and BeiGene Advance Subcutaneous Formulation of FIC Bispecific Antibody into Phase III Trial

Deep News
·
Jul 23

Sino Biopharmaceutical Stock Slips 3.0% in Hong Kong, Underperforms Competitors

Dow Jones
·
Jul 23

Sector Update: Healthcare Stocks Softer Late Afternoon

MT Newswires Live
·
Jul 23